Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06475898 · ClinicalTrials.gov registry record
Longitudinal Endpoint Assessment of Disease Burden in HD
A clinical trial of Huntington Disease, sponsored by Huntington Study Group.
- Recruiting
- Registry status
- 600
- Enrollment target
- 1
- Study location
NCT06475898 is a study of Huntington Disease that is actively recruiting participants, run by Huntington Study Group. The registered enrollment target is 600 participants, roughly in line with the 618-participant average among 35 other Huntington Disease trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT06475898, a study of Huntington Disease, is actively recruiting participants, sponsored by Huntington Study Group.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
LEAD-HD is intended to collect and analyze self-reported health information from individuals with Huntington Disease (HD) or prodromal HD participating in a 24-month longitudinal natural history study using remote technologies.
Conditions Studied
Study Locations (1)
New York
- Huntington Study Group - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2024-06-25 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06475898
The ClinicalTrials.gov registry entry for NCT06475898 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 618-participant average among 35 other Huntington Disease trials with a reported enrollment target. The listed sponsor is Huntington Study Group, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Huntington Disease appearing as the primary indexed condition, and to 0 interventions.
NCT06475898 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06475898 about?
NCT06475898 is a clinical study titled "Longitudinal Endpoint Assessment of Disease Burden in HD". LEAD-HD is intended to collect and analyze self-reported health information from individuals with Huntington Disease (HD) or prodromal HD participating in a 24-month longitudinal natural history study using remote technologies.
What is the current status of trial NCT06475898?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2024-06-25. Estimated completion is 2026-12.
What conditions does trial NCT06475898 study?
This clinical trial studies the following conditions: Huntington Disease.
Who is sponsoring clinical trial NCT06475898?
This trial is sponsored by Huntington Study Group, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06475898 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Huntington Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers
RECRUITING
-
Extracellular Vesicles for HD
RECRUITING
-
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
RECRUITING · Phase 3
-
A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease
RECRUITING · Phase 1
-
Gut Microbiomes in HD
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.